TY  - GEN
AU  - Bellone,S
AU  - Roque,D
AU  - Cocco,E
AU  - Gasparrini,S
AU  - Bortolomai,I
AU  - Buza,N
AU  - Abu-Khalaf,M
AU  - Silasi,D-A
AU  - Ratner,E
AU  - Azodi,M
AU  - Schwartz,P E
AU  - Rutherford,T J
AU  - Pecorelli,S
AU  - Santin,A D
TI  - Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy
SN  - 1532-1827
PY  - 2012///0619
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - immunology
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Antibody-Dependent Cell Cytotoxicity
KW  - CD55 Antigens
KW  - chemistry
KW  - CD59 Antigens
KW  - Complement Activation
KW  - Cystadenocarcinoma, Serous
KW  - genetics
KW  - Cytotoxicity, Immunologic
KW  - Down-Regulation
KW  - Female
KW  - Flow Cytometry
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Membrane Cofactor Protein
KW  - Middle Aged
KW  - Prognosis
KW  - RNA, Small Interfering
KW  - Real-Time Polymerase Chain Reaction
KW  - Receptor, ErbB-2
KW  - Trastuzumab
KW  - Uterine Cervical Neoplasms
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bjc.2012.132
ER  -